Enhanced recognition of cystic fibrosis W1282X DNA point mutation by chiral peptide nucleic acid probes by a surface plasmon resonance biosensor

Journal of Molecular Recognition

Volumn 17, Issue 1, 2004, Pages 76-84

  Corradini, Roberto ^a   Feriotto, Giordana ^b   Sforza, Stefano ^a   Marchelli, Rosangela ^a   Gambari, Roberto ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Biacore; Chirality; Cystic fibrosis; Peptide nucleic acids; Point mutation; Surface plasmon resonance

Indexed keywords

LYSINE; PEPTIDE NUCLEIC ACID;

ARTICLE; CHEMISTRY; CYSTIC FIBROSIS; GENETICS; HUMAN; INSTRUMENTATION; METHODOLOGY; MISSENSE MUTATION; NUCLEIC ACID HYBRIDIZATION; POINT MUTATION; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; SYNTHESIS; TRANSITION TEMPERATURE;

CYSTIC FIBROSIS; HUMANS; LYSINE; MUTATION, MISSENSE; NUCLEIC ACID HYBRIDIZATION; PEPTIDE NUCLEIC ACIDS; POINT MUTATION; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; TRANSITION TEMPERATURE;

BIA;

EID: 1242344159     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.646     Document Type: Article

References (39)

1. Burgener M, Sanger M, Candrian U. 2000. Synthesis of a stable and specific surface plasmon resonance biosensor surface employing covalently immobilized peptide nucleic acids. Bioconjug. Chem. 11: 749-754.
2. Cutrona G, Carpaneto EM, Ulivi M, Roncella S, Landt O, Ferrarini M, Boffa LC. 2000. Effect in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat. Biotech. 18: 300-303.
3. 10 peptide nucleic acid. J. Biol. Chem. 276: 5720-5725.
4. Dueholm KL, Nielsen PE. 1997. Chemistry, properties and applications of PNA (peptide nucleic acid). New J. Chem. 21: 19-31.
5. Egholm M, Buchardt O, Nielsen PE, Berg RH. 1992. Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone. J. Am. Chem. Soc. 114: 1895-1897.
6. Egholm M, Buchardt P, Christensen L, Behrens C, Freier SM, Driver DA, Berg R, Kim SK, Norden B, Nielsen PE. 1993. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365: 566-568.
7. Feriotto G, Lucci M, Bianchi N, Mischiati C, Gambari R. 1999. Detection of the ΔF508 (F508del) mutation of the cystic fibrosis gene by surface plasmon resonance and biosensor technology. Hum. Mutat. 13: 390-400.
8. Feriotto G, Corradini R, Sforza S, Bianchi N, Mischiati C, Marchelli R, Gambari R. 2001. Peptide nucleic acids and biosensor technology for real-time detection of the cystic fibrosis W1258X mutation by surface plasmon resonance. Lab. Invest. 81: 1415-1427.
9. Ganesh KN, Nielsen PE. 2000. Peptide nucleic acids: analogs and derivatives. Curr. Org. Chem. 4: 931-943.
10. Good L, Nielsen PE. 1998. Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat. Biotech. 16: 355-358.
11. Griffin TJ, Tang W, Smith LM. 1997. Genetic analysis by Peptide Nucleic Acids affinity MALDI-TOF mass spectrometry. Nat. Biotech. 15: 1368-1372.
12. Haaima G, Lohse A, Buchardt O, Nielsen PE. 1996. Peptide nucleic acids (PNAs) containing thymine monomers derived from chiral amino acids: hybridization and solubility properties of D-lysine PNA. Angew. Chem. Int. Edn Engl. 35: 1939-1942.
13. Hyrup B, Egholm M, Nielsen PE, Wittung P, Nordén B, Buchardt O. 1994. Structure-activity studies of the binding of modified peptide nucleic acids (PNAs) to DNA. J. Am. Chem. Soc. 116: 7964-7970.
14. Igloi GL. 1999. Automated detection of point mutations by electrophoresis in peptide nucleic acid-containing gels. Biotechniques 27: 798-808.
15. Jensen KK, Ørum H, Nielsen PE, Nordén B. 1997. Kinetics of hybridization of peptide nucleic acids (PNA) with the BIAcore technique. Biochemistry 36: 5072-5077.
16. Knudsen H, Nielsen PE. 1997. Application of peptide nucleic acid in cancer therapy. Anti-Cancer Drugs 8: 113-118.
17. Koch T, Hansen HF, Andersen P, Larsen T, Batz HG, Otteson K, Ørum H. 1997. Improvements in authomated PNA synthesis using Boc/Z monomers. J. Pept. Res. 49: 80-88.
18. Menchise V, De Simone G, Corradini R, Sforza S, Sorrentino N, Romanelli A, Saviano M, Pedone C. 2002. Crystallization and preliminary X-ray diffraction studies of a D-lysine chiral PNA-DNA duplex. Acta Crystall D 58: 553-555.
19. Mologni L, Marchesi E, Nielsen PE, Gambacorti-Passerini C. 2001. Inhibition of promyelicytic leucemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukaemia cells by anti-PML peptide nucleic acid. Cancer Res. 61: 5468-5473.
20. Nielsen PE. 2001. Peptide nucleic acid: a versatile tool in genetic diagnostics and molecular biology. Curr. Opin. Biotech. 12: 16-20.
21. Nielsen PE, Egholm M (eds). Peptide Nucleic Acids. Protocols and Applications. Horizon Scientific Press: Wymondham, 1999.
22. Nielsen PE, Haaima G. 1997. Peptide nucleic acid (PNA). A DNA mimic with a pseudopeptide backbone. Chem. Soc. Rev. 26: 73-78.
23. Nielsen PE, Egholm M, Berg RH, Buchardt O. 1991. Sequence selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254: 1497-1500.
24. Nielsen PE, Egholm M, Berg RH, Buchardt O. 1993. Sequence specific inhibition of restriction enzyme cleavage by PNA. Nucl. Acids Res. 21: 197-200.
25. Nielsen PE, Egholm M, Buchardt O. 1994. Sequence specific transcription arrest by PNA bound to the template strand. Gene 149: 139-145.
26. Ørum H, Nielsen PE, Egholm M, Berg RH, Buchardt O, Stanley C. 1993. Single base pair mutation analysis by PNA directed PCR clamping. Nucl. Acids Res. 21: 5332-5336.
27. Sawata S, Kai E, Ikebukuro K, Iida T, Honda T, Karube I. 1999. Application of peptide nucleic acid to the direct detection of deoxyribonucleic acid amplified by polymerase chain reaction. Biosens. Bioelectron. 14: 397-404.
28. Sforza S, Haaima G, Marchelli R, Nielsen PE. 1999. Chiral peptide nucleic acids (PNAs) helix handedness and DNA recognition. Eur. J. Org. Chem. 197-204.
29. Sforza S, Corradini R, Ghirardi S, Dossena A, Marchelli R. 2000. DNA binding of a D-lysine-based chiral PNA: direction control and mismatch recognition. Eur. J. Org. Chem. 2905-2913.
30. Sforza S, Galaverna G, Dossena A, Corradini R, Marchelli R. 2002. Role of Chirality and Optical purity in nucleic acid recognition by PNA and PNA Analogs. Chirality 14: 591-598.
31. Sforza S, Tedeschi T, Corradini T, Dossena A, Marchelli R. 2003. Direction control in DNA binding of chiral D-lysine-based peptide nucleic acid (PNA) probed by electrospray mass spectrometry. Chem. Commun. 1102-1103.
32. Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, Tal A, Seret H, Yaar L, Kerem E, Kerem B. 1992. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cysticfibrosis patients in Israel, with presentation of severe disease. Am. J. Hum. Genet. 50: 222-228.
33. Smith JO, Olson DA, Armitage BA. 1999. Molecular recognition of PNA-containing hybrids: spontaneous assembly of helical cyanine dye aggregates on PNA templates. J. Am. Chem. Soc. 121: 2686-2695.
34. Vidaud M, Fanen P, Martin J, Ghanem N, Nicolas S, Goossens M. 1990. Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. Hum. Genet. 85: 446-449.
35. Wang J. 1998. DNA biosensors based on peptide nucleic acid (PNA) recognition layers. Biosens. Bioelectron. 13: 757-762.
36. Wang J, Rivas G, Cai X. 1997a. Detection of point mutation in the p53 gene using peptide nucleic acid biosensor. Anal. Chim. Acta 344: 111-118.
37. Wang J, Nielsen PE, Jiang M, Cai X, Fernandes JR, Grant DH, Ozsoz M, Beglieter A, Mowat M. 1997b. Mismatch-sensitive hybridization detection by peptide nucleic acids immobilized on a quartz crystal microbalance. Anal. Chem. 69: 5200-5202.
38. Weiler J, Gausepohl H, Hauser N, Jensen ON, Hoeisel JD. 1997. Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays. Nucl. Acids Res. 25: 2792-2799.
39. Wong LJ, Wang J, Woo M, Hsu E, Bowman CM. 2000. A novel mutation detected by temporal temperature gradient gel electrophoresis led to the confirmative prenatal diagnosis of a Hispanic CF family. Prenat. Diagn. 20: 807-810.